Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025)
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
J Transl Med, 23 (1), 672
DOI 10.1186/s12967-025-06644-7, PubMed 40528241

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer (in press)
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Commun Med (Lond), 5 (1), 234
DOI 10.1038/s43856-025-00865-z, PubMed 40523912

Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025)
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
J Transl Med, 23 (1), 672
DOI 10.1186/s12967-025-06644-7, PubMed 40528241

Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Commun Med (Lond), 5 (1), 234
DOI 10.1038/s43856-025-00865-z, PubMed 40523912

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer (in press)
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692